230 related articles for article (PubMed ID: 9820184)
1. Bone morphogenetic protein 6 in skeletal metastases from prostate cancer and other common human malignancies.
Autzen P; Robson CN; Bjartell A; Malcolm AJ; Johnson MI; Neal DE; Hamdy FC
Br J Cancer; 1998 Nov; 78(9):1219-23. PubMed ID: 9820184
[TBL] [Abstract][Full Text] [Related]
2. Immunolocalization and messenger RNA expression of bone morphogenetic protein-6 in human benign and malignant prostatic tissue.
Hamdy FC; Autzen P; Robinson MC; Horne CH; Neal DE; Robson CN
Cancer Res; 1997 Oct; 57(19):4427-31. PubMed ID: 9331107
[TBL] [Abstract][Full Text] [Related]
3. Influence of BMPs on the formation of osteoblastic lesions in metastatic prostate cancer.
Feeley BT; Gamradt SC; Hsu WK; Liu N; Krenek L; Robbins P; Huard J; Lieberman JR
J Bone Miner Res; 2005 Dec; 20(12):2189-99. PubMed ID: 16294272
[TBL] [Abstract][Full Text] [Related]
4. Role of bone morphogenetic proteins in human prostate cancer pathogenesis and development of bone metastases: immunohistochemical study.
Spanjol J; Djordjević G; Markić D; Klarić M; Fuckar D; Bobinac D
Coll Antropol; 2010 Apr; 34 Suppl 2():119-25. PubMed ID: 21302710
[TBL] [Abstract][Full Text] [Related]
5. Bone morphogenetic protein-6 promotes osteoblastic prostate cancer bone metastases through a dual mechanism.
Dai J; Keller J; Zhang J; Lu Y; Yao Z; Keller ET
Cancer Res; 2005 Sep; 65(18):8274-85. PubMed ID: 16166304
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of bone morphogenetic protein-7 in bone metastatic prostate cancer.
Masuda H; Fukabori Y; Nakano K; Takezawa Y; CSuzuki T; Yamanaka H
Prostate; 2003 Mar; 54(4):268-74. PubMed ID: 12539225
[TBL] [Abstract][Full Text] [Related]
7. Targeting the BMP Pathway in Prostate Cancer Induced Bone Disease.
Straign DM; Ihle CL; Provera MD; Owens P
Front Endocrinol (Lausanne); 2021; 12():769316. PubMed ID: 34956082
[TBL] [Abstract][Full Text] [Related]
8. Bone morphogenetic proteins and their receptor signaling in prostate cancer.
Ye L; Lewis-Russell JM; Kyanaston HG; Jiang WG
Histol Histopathol; 2007 Oct; 22(10):1129-47. PubMed ID: 17616940
[TBL] [Abstract][Full Text] [Related]
9. Expression of bone morphogenetic proteins in human metastatic prostate and breast cancer.
Bobinac D; Marić I; Zoricić S; Spanjol J; Dordević G; Mustać E; Fuckar Z
Croat Med J; 2005 Jun; 46(3):389-96. PubMed ID: 15861517
[TBL] [Abstract][Full Text] [Related]
10. Expression of bone morphogenetic protein messenger RNAs by normal rat and human prostate and prostate cancer cells.
Harris SE; Harris MA; Mahy P; Wozney J; Feng JQ; Mundy GR
Prostate; 1994 Apr; 24(4):204-11. PubMed ID: 8146069
[TBL] [Abstract][Full Text] [Related]
11. Expression of bone morphogenetic proteins in human prostatic adenocarcinoma and benign prostatic hyperplasia.
Bentley H; Hamdy FC; Hart KA; Seid JM; Williams JL; Johnstone D; Russell RG
Br J Cancer; 1992 Dec; 66(6):1159-63. PubMed ID: 1280991
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of noggin inhibits BMP-mediated growth of osteolytic prostate cancer lesions.
Feeley BT; Krenek L; Liu N; Hsu WK; Gamradt SC; Schwarz EM; Huard J; Lieberman JR
Bone; 2006 Feb; 38(2):154-66. PubMed ID: 16126463
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor contributes to the prostate cancer-induced osteoblast differentiation mediated by bone morphogenetic protein.
Dai J; Kitagawa Y; Zhang J; Yao Z; Mizokami A; Cheng S; Nör J; McCauley LK; Taichman RS; Keller ET
Cancer Res; 2004 Feb; 64(3):994-9. PubMed ID: 14871830
[TBL] [Abstract][Full Text] [Related]
14. Skeletal metastasis of prostate adenocarcinoma in rats: morphometric analysis and role of parathyroid hormone-related protein.
Blomme EA; Dougherty KM; Pienta KJ; Capen CC; Rosol TJ; McCauley LK
Prostate; 1999 May; 39(3):187-97. PubMed ID: 10334108
[TBL] [Abstract][Full Text] [Related]
15. Bone morphogenetic protein (BMP)-6 signaling and BMP antagonist noggin in prostate cancer.
Haudenschild DR; Palmer SM; Moseley TA; You Z; Reddi AH
Cancer Res; 2004 Nov; 64(22):8276-84. PubMed ID: 15548695
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic regulation of human bone morphogenetic protein 6 gene expression in prostate cancer.
Tamada H; Kitazawa R; Gohji K; Kitazawa S
J Bone Miner Res; 2001 Mar; 16(3):487-96. PubMed ID: 11277266
[TBL] [Abstract][Full Text] [Related]
17. Characterization of osteoblastic and osteolytic proteins in prostate cancer bone metastases.
Larson SR; Zhang X; Dumpit R; Coleman I; Lakely B; Roudier M; Higano CS; True LD; Lange PH; Montgomery B; Corey E; Nelson PS; Vessella RL; Morrissey C
Prostate; 2013 Jun; 73(9):932-40. PubMed ID: 23334979
[TBL] [Abstract][Full Text] [Related]
18. Prostate carcinoma skeletal metastases: cross-talk between tumor and bone.
Keller ET; Zhang J; Cooper CR; Smith PC; McCauley LK; Pienta KJ; Taichman RS
Cancer Metastasis Rev; 2001; 20(3-4):333-49. PubMed ID: 12085970
[TBL] [Abstract][Full Text] [Related]
19. Bone sialoprotein, bone morphogenetic protein 6 and thymidine phosphorylase expression in localized human prostatic adenocarcinoma as predictors of clinical outcome: a clinicopathological and immunohistochemical study of 43 cases.
De Pinieux G; Flam T; Zerbib M; Taupin P; Bellahcène A; Waltregny D; Vieillefond A; Poupon MF
J Urol; 2001 Nov; 166(5):1924-30. PubMed ID: 11586262
[TBL] [Abstract][Full Text] [Related]
20. Diverse biological effect and Smad signaling of bone morphogenetic protein 7 in prostate tumor cells.
Yang S; Zhong C; Frenkel B; Reddi AH; Roy-Burman P
Cancer Res; 2005 Jul; 65(13):5769-77. PubMed ID: 15994952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]